ATNF insider filings
180 Life Sciences Corp. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2025-08-12. Screen ATNF transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for ATNF between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — 180 Life Sciences Corp.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-08-12 | 4 | Rudisill McAndrew — Director | Grant/award (A): 957,002 (derivative) @ $0 | EDGAR |
| 2025-08-11 | 4 | Shoemaker Stephen H — Director | Grant/award (A): 181,422 (derivative) @ $0 | EDGAR |
| 2025-08-11 | 4 | Jordan Blair — Chief Executive Officer, Director | Grant/award (A): 771,044 (derivative) @ $0 | EDGAR |
| 2025-08-11 | 4 | Smith Ryan Lewis — Director | Grant/award (A): 771,044 (derivative) @ $0 | EDGAR |
| 2025-08-07 | 4 | Shoemaker Stephen H — Director | Grant/award (A): 919,761 (derivative) @ $0 | EDGAR |
| 2025-08-06 | 4 | Jordan Blair — Chief Executive Officer, Director, 10% owner | Grant/award (A): 3,908,986 (derivative) @ $0 | EDGAR |
| 2025-08-06 | 4 | Smith Ryan Lewis — Director | Grant/award (A): 3,908,986 (derivative) @ $0 | EDGAR |
| 2025-07-14 | 4 | Shoemaker Stephen H — Director | Holdings only — no transactions reported | EDGAR |
| 2025-07-14 | 4 | Van Lent Eric R — Chief Accounting Officer | Holdings only — no transactions reported | EDGAR |
| 2025-07-14 | 4 | Jordan Blair — Chief Executive Officer, Director, 10% owner | Other (J): 160,000 · Other (J): 160,000 | EDGAR |
| 2025-07-14 | 4 | Smith Ryan Lewis — Director | Holdings only — no transactions reported | EDGAR |
| 2025-07-14 | 4 | STEINMAN LAWRENCE — Director | Holdings only — no transactions reported | EDGAR |
| 2025-06-30 | 4/A | Shoemaker Stephen H — Director | Grant/award (A): 67,439 @ $0 · Grant/award (A): 165,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4/A | Jordan Blair — Chief Executive Officer, Director, 10% owner | Grant/award (A): 167,576 @ $0 · Grant/award (A): 410,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4/A | Van Lent Eric R — Chief Accounting Officer | Grant/award (A): 8,174 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4/A | Smith Ryan Lewis — Director | Grant/award (A): 102,181 @ $0 · Grant/award (A): 255,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4/A | STEINMAN LAWRENCE — Director | Grant/award (A): 44,959 @ $0 · Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Shoemaker Stephen H — Director | Grant/award (A): 72,297 @ $0 · Grant/award (A): 165,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Jordan Blair — Chief Executive Officer, Director, 10% owner | Grant/award (A): 179,646 @ $0 · Grant/award (A): 410,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Van Lent Eric R — Chief Accounting Officer | Grant/award (A): 8,763 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Smith Ryan Lewis — Director | Grant/award (A): 109,541 @ $0 · Grant/award (A): 255,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | STEINMAN LAWRENCE — Director | Grant/award (A): 48,198 @ $0 · Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2025-04-30 | 4 | Jordan Blair — Chief Executive Officer, Director, 10% owner | Other (J): 1,318,000 @ $0 | EDGAR |
| 2025-04-11 | 4 | ELRAY RESOURCES, INC. — 10% owner | Conversion (C): 1,318,000 · Conversion (C): 1,000,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Jordan Blair — Chief Executive Officer, Director | Other (J): 200,000 @ $0 | EDGAR |
| 2025-02-24 | 4 | Shoemaker Stephen H — Director | Grant/award (A): 65,000 @ $0 | EDGAR |
| 2025-02-21 | 4 | Goodman Jay Lawrence — Director | Grant/award (A): 65,000 @ $0 | EDGAR |
| 2025-02-21 | 4 | Jordan Blair — Chief Executive Officer, Director | Grant/award (A): 160,000 @ $0 | EDGAR |
| 2025-02-21 | 4 | Smith Ryan Lewis — Director | Grant/award (A): 65,000 @ $0 | EDGAR |
| 2025-02-21 | 4 | STEINMAN LAWRENCE — Director | Grant/award (A): 65,000 @ $0 | EDGAR |
| 2025-02-07 | 4 | Jordan Blair — Chief Executive Officer, Director | Other (J): 43,166 @ $0 | EDGAR |
| 2023-12-28 | 4 | Feldmann Marc — Director | Grant/award (A): 135,377 @ $0 | EDGAR |
| 2023-12-18 | 4 | Feldmann Marc — Director | Sale (S): 25,000 @ $0.19 | EDGAR |
| 2023-12-18 | 4 | Woody James N. — Chief Executive Officer, Director | Purchase (P): 25,000 @ $0.19 | EDGAR |
| 2023-09-08 | 4 | Feldmann Marc — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2023-09-08 | 4 | Rothbard Jonathan B. — Chief Scientific Officer | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2023-09-08 | 4 | DeLuca Teresa — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2023-09-08 | 4 | Woody James N. — Chief Executive Officer, Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2023-09-08 | 4 | Francis Knuettel II — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2023-09-08 | 4 | RAY RUSSELL T — Director | Grant/award (A): 21,455 @ $1.36 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2023-09-06 | 4 | Pamir Ozan — CFO | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2023-09-06 | 4 | McGovern Jr. Donald A. — Director | Grant/award (A): 25,186 @ $0 · Grant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 44,776 (derivative) @ $0 | EDGAR |
| 2023-09-06 | 4 | Marrone Pamela G — Director | Grant/award (A): 22,388 @ $0 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2023-09-06 | 4 | Gold Lawrence Marshall — Director | Grant/award (A): 21,455 @ $0 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2023-09-06 | 4 | STEINMAN LAWRENCE — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2023-06-02 | 4 | STEINMAN LAWRENCE — Director | Purchase (P): 18,000 @ $1.23 | EDGAR |
| 2023-06-01 | 4 | McGovern Jr. Donald A. — Director | Purchase (P): 10,000 @ $1.15 | EDGAR |
| 2023-05-22 | 4 | McGovern Jr. Donald A. — Director | Purchase (P): 10,000 @ $1.05 · Purchase (P): 5,000 @ $1.16 | EDGAR |
| 2023-05-19 | 4 | Pamir Ozan — CFO | Purchase (P): 5,162.08 @ $1.01 | EDGAR |
| 2023-05-19 | 4 | Marrone Pamela G — Director | Purchase (P): 7,082.02 @ $1.06 | EDGAR |
Recent 8-K events — 180 Life Sciences Corp.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-10-05 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-21 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-08-19 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-30 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-16 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-01 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-30 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-29 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-24 | 8-K | 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ATNF returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →